Crunching the numbers for BMRA... Refresh in a moment for the full analysis.
BIOMERICA INC (BMRA)
Healthcare
weak
$2.13
Updated: 2026-04-13
44
TradeApes Score
reduce
Financial Strength
65
Healthy
Operating Trend
30
Weak
Valuation
40
Weak
Capital Allocation
30
Weak
Risk
55
Mixed
Key Findings
+
Low leverage — net debt/EBITDA below 1×
−
Sharp revenue decline — sales down more than 15% year over year
4 free score cards remaining
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.